Smith & Nephew SNATS Income After Taxes 2010-2024 | SNN
Smith & Nephew SNATS annual/quarterly income after taxes history and growth rate from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
- Smith & Nephew SNATS income after taxes for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
- Smith & Nephew SNATS income after taxes for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
- Smith & Nephew SNATS annual income after taxes for 2024 was $0.412B, a 56.65% increase from 2023.
- Smith & Nephew SNATS annual income after taxes for 2023 was $0.263B, a 17.94% increase from 2022.
- Smith & Nephew SNATS annual income after taxes for 2022 was $0.223B, a 57.44% decline from 2021.
| Smith & Nephew SNATS Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2024 | $412 |
| 2023 | $263 |
| 2022 | $223 |
| 2021 | $524 |
| 2020 | $448 |
| 2019 | $600 |
| 2018 | $663 |
| 2017 | $767 |
| 2016 | $784 |
| 2015 | $410 |
| 2014 | $501 |
| 2013 | $556 |
| 2012 | $729 |
| 2011 | $582 |
| 2010 | $615 |
| 2009 | $472 |
| Smith & Nephew SNATS Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2024-12-31 | |
| 2024-06-30 | |
| 2023-12-31 | |
| 2023-06-30 | |
| 2022-12-31 | |
| 2022-06-30 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| 2020-06-30 | |
| 2019-12-31 | |
| 2019-06-30 | |
| 2018-12-31 | |
| 2018-06-30 | |
| 2017-12-31 | |
| 2017-06-30 | |
| 2016-12-31 | |
| 2015-12-31 | |
| 2015-06-30 | |
| 2014-12-31 | $160 |
| 2014-09-30 | $102 |
| 2014-06-30 | $89 |
| 2014-03-31 | $150 |
| 2013-12-31 | $162 |
| 2013-09-30 | $122 |
| 2013-06-30 | $129 |
| 2013-03-31 | $143 |
| 2012-12-31 | $142 |
| 2012-09-30 | $134 |
| 2012-06-30 | $292 |
| 2012-03-31 | $161 |
| 2011-12-31 | $140 |
| 2011-09-30 | $133 |
| 2011-06-30 | $153 |
| 2011-03-31 | $156 |
| 2010-12-31 | $182 |
| 2010-09-30 | $137 |
| 2010-06-30 | $137 |
| 2010-03-31 | $159 |
| 2009-12-31 | $128 |
| 2009-09-30 | $128 |
| 2009-06-30 | $118 |
| 2009-03-31 | $98 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $13.547B | $5.810B |
| Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $218.750B | 25.66 |
| Boston Scientific (BSX) | United States | $152.620B | 38.21 |
| Stryker (SYK) | United States | $150.824B | 31.54 |
| EssilorLuxottica (ESLOY) | France | $131.932B | 0.00 |
| Medtronic (MDT) | Ireland | $117.545B | 16.66 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.596B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.351B | 24.74 |
| ResMed (RMD) | United States | $39.208B | 29.45 |
| GE HealthCare Technologies (GEHC) | United States | $35.024B | 16.63 |
| Agilent Technologies (A) | United States | $33.005B | 21.52 |
| Koninklijke Philips (PHG) | Netherlands | $24.092B | 16.91 |
| Terumo (TRUMY) | Japan | $23.645B | 30.71 |
| Insulet (PODD) | United States | $20.097B | 78.89 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.096B | 12.26 |
| Baxter (BAX) | United States | $14.117B | 10.54 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.680B | 23.25 |
| Lantheus Holdings (LNTH) | United States | $5.005B | 12.62 |
| Perrigo (PRGO) | Ireland | $3.788B | 9.60 |
| Prestige Consumer Healthcare (PBH) | United States | $3.776B | 16.87 |
| Haemonetics (HAE) | United States | $3.565B | 16.24 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.397B | 28.23 |
| ICU Medical (ICUI) | United States | $3.107B | 22.91 |
| LeMaitre Vascular (LMAT) | United States | $1.816B | 40.60 |
| QuidelOrtho (QDEL) | United States | $1.727B | 11.88 |
| AtriCure (ATRC) | United States | $1.454B | 0.00 |
| Acuren (TIC) | United States | $1.435B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.279B | 12.99 |
| Green Thumb Industries (GTBIF) | United States | $1.243B | 27.96 |
| Phibro Animal Health (PAHC) | United States | $1.185B | 15.15 |
| Neogen (NEOG) | United States | $1.090B | 13.94 |
| BioLife Solutions (BLFS) | United States | $1.024B | 0.00 |
| InMode (INMD) | Israel | $0.911B | 9.18 |
| Kestra Medical Technologies (KMTS) | United States | $0.874B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.791B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.784B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.644B | 0.00 |
| Owens & Minor (OMI) | United States | $0.626B | 5.19 |
| Evolus (EOLS) | United States | $0.617B | 0.00 |
| CeriBell (CBLL) | United States | $0.561B | 0.00 |
| Valneva SE (VALN) | France | $0.530B | 0.00 |
| ZimVie (ZIMV) | United States | $0.522B | 23.71 |
| Surmodics (SRDX) | United States | $0.456B | 0.00 |
| SNDL (SNDL) | Canada | $0.431B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.315B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.312B | 11.48 |
| Cresco Labs (CRLBF) | United States | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.303B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.298B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.284B | 84.17 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| Cerus (CERS) | United States | $0.273B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.258B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.257B | 21.67 |
| Canopy Growth (CGC) | Canada | $0.256B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.234B | 0.00 |
| Brainsway (BWAY) | Israel | $0.229B | 60.50 |
| Biote (BTMD) | United States | $0.225B | 6.34 |
| Verano Holdings (VRNOF) | United States | $0.220B | 0.00 |
| Omeros (OMER) | United States | $0.219B | 0.00 |
| Organigram Global (OGI) | Canada | $0.208B | 0.00 |
| High Tide (HITI) | Canada | $0.195B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 14.93 |
| TriSalus Life Sciences (TLSI) | United States | $0.170B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.153B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.124B | 15.32 |
| TerrAscend (TSNDF) | Canada | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.77 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.084B | 0.00 |
| Safety Shot (SHOT) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.062B | 0.00 |
| United-Guardian (UG) | United States | $0.044B | 15.11 |
| Rockwell Medical (RMTI) | United States | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Nephros (NEPH) | United States | $0.037B | 50.14 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |